Amedisys/ US0234361089 /
2024-11-12 9:59:58 PM | Chg. -1.68 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
90.96USD | -1.81% | 197,554 Turnover: 18.02 mill. |
-Bid Size: - | -Ask Size: - | 2.98 bill.USD | - | - |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 148.5000 | 156.7000 | 159 | 137.4550 | 42.6950 | ||||||
Intangible Assets | 50.1000 | 47.1000 | 36.7000 | 33.1930 | 44.0470 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | 534.1840 | 509.8220 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 148.1000 | 169.2000 | 111.1000 | 99.3250 | 125.0100 | ||||||
Cash and Cash Equivalents | 48 | 14.5000 | 17.3000 | 8.0320 | 27.5020 | ||||||
Current Assets | 232 | 205.8000 | 205.3000 | 135.5580 | 175.2630 | ||||||
Total Assets | 858.3000 | 730.6000 | 726.4000 | 669.7420 | 685.0850 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 25.5000 | 29.2000 | 20.1000 | 16.0560 | 25.6820 | ||||||
Long-term debt | 111.6000 | 66.9000 | 33 | 104.3720 | 95 | ||||||
Liabilities to Banks | 145.5000 | 102.7000 | 46.9000 | 116.4000 | 100 | ||||||
Provisions | 11.7000 | 5.6000 | - | 2.4000 | - | ||||||
Liabilities | 338.1000 | 276.4000 | 353.9000 | 271.9800 | 274.6490 | ||||||
Share Capital | 0.0000 | .0300 | .0300 | .0350 | .0350 | ||||||
Total Equity | 520.1000 | 454.2000 | 372.5000 | 397.7620 | 410.4360 | ||||||
Minority Interests | 1.3000 | 1.9000 | .3000 | .5950 | .8680 | ||||||
Total liabilities equity | 858.3000 | 730.6000 | 726.4000 | 669.7420 | 685.0850 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,470.4000 | 1,487.9000 | 1,249.3000 | 1,204.5540 | 1,280.5410 | ||||||
Depreciation (total) | 38.6000 | 39.9000 | 36.9000 | 28.3470 | 20.0360 | ||||||
Operating Result | -470.9000 | -112.2000 | -155 | 24.0470 | -9.1660 | ||||||
Interest Income | -8.6000 | -12.1300 | -4.3500 | -8.1230 | -10.7120 | ||||||
Income Before Taxes | -478.8000 | -118.7000 | -153.5000 | 20.9760 | -.3080 | ||||||
Income Taxes | -103.4000 | -21.4000 | -58.8000 | -7.6710 | -2.0040 | ||||||
Minority Interests Profit | -.1000 | 15 | 1.6000 | -.3130 | -.7090 | ||||||
Net Income | -382.5000 | -83.6000 | -96.2000 | 12.7760 | -3.0210 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 141.7000 | 69.5000 | 102.3000 | -65.5340 | 107.7850 | ||||||
Cash Flow from Investing Activities | -180.7000 | -60 | -46.5000 | -14.3000 | -67.4210 | ||||||
Cash Flow from Financing | -33.2000 | -43 | -53 | 70.5630 | -20.8940 | ||||||
Decrease / Increase in Cash | -72.3000 | -33.5000 | 2.8000 | -9.2710 | 19.4700 | ||||||
Employees | 16,500 | 15,200 | 14,300 | 13,200 | 16,100 |